| Literature DB >> 31595428 |
Anna Tampieri1, Monica Sandri1, Michele Iafisco1, Silvia Panseri1, Monica Montesi1, Alessio Adamiano1, Massimiliano Dapporto1, Elisabetta Campodoni1, Samuele M Dozio1, Lorenzo Degli Esposti1, Simone Sprio2.
Abstract
The aging of the world population is increasingly claimed as an alarming situation, since an ever-raising number of persons in advanced age but still physically active is expected to suffer from invalidating and degenerative diseases. The impairment of the endogenous healing potential provoked by the aging requires the development of more effective and personalized therapies, based on new biomaterials and devices able to direct the cell fate to stimulate and sustain the regrowth of damaged or diseased tissues. To obtain satisfactory results, also in cases where the cell senescence, typical of the elderly, makes the regeneration process harder and longer, the new solutions have to possess excellent ability to mimic the physiological extracellular environment and thus exert biomimetic stimuli on stem cells. To this purpose, the "biomimetic concept" is today recognized as elective to fabricate bioactive and bioresorbable devices such as hybrid osteochondral scaffolds and bioactive bone cements closely resembling the natural hard tissues and with enhanced regenerative ability. The review will illustrate some recent results related to these new biomimetic materials developed for application in different districts of the musculoskeletal system, namely bony, osteochondral and periodontal regions, and the spine. Further, it will be shown how new bioactive and superparamagnetic calcium phosphate nanoparticles can give enhanced results in cardiac regeneration and cancer therapy. Since tissue regeneration will be a major demand in the incoming decades, the high potential of biomimetic materials and devices is promising to significantly increase the healing rate and improve the clinical outcomes even in aged patients.Entities:
Keywords: Biomimetic materials; Bioresorbable nanoparticles; Cell therapy; Osteoarthritis; Osteoporosis; Regenerative medicine
Mesh:
Year: 2019 PMID: 31595428 DOI: 10.1007/s40520-019-01365-6
Source DB: PubMed Journal: Aging Clin Exp Res ISSN: 1594-0667 Impact factor: 3.636